une 11, 2013 -- VANCOUVER - An FDG-PET/CT scan illustrating the effectiveness of radium-223 dichloride in treating bone metastases in breast cancer patients with bone-dominant disease has been selected as the Image of the Year at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
The images come from the department of nuclear medicine at the Institut Jules Bordet in Brussels and were selected from more than 2,000 studies. The research is scheduled for presentation on Wednesday by lead author Dr. Patrick Flamen.
In making the announcement, Dr. Peter Herscovitch, chair of SNMMI's scientific program committee, said the image "shows the results of molecular imaging therapy and shows how molecular imaging with FDG-PET can be used to show the response of tumors to therapy.